Peking University Cancer Hospital
Beijing · Onkologi · 3A
Fudan 2022 · #66 3A
Ikhtisar
Peking University Cancer Hospital adalah rumah sakit unggulan di Beijing, Tiongkok. Rumah sakit ini masuk dalam 100 Besar MedTravelCN karena keunggulannya di bidang Onkologi dan kemampuannya menerima pasien internasional.
A national cancer hospital known for gastrointestinal oncology; its standardised gastric and colorectal cancer pathways are widely adopted.
Informasi utama
| Tahun berdiri | 1976 |
|---|---|
| Kota | Beijing |
| Spesialisasi unggulan | Onkologi |
| Akreditasi | 3A |
| Peringkat Fudan 2022 | #66 |
Alamat & lokasi
Departemen unggulan
Tren peringkat (peringkat Fudan, rentang referensi)
2021
2022
2023
2024
2025
Rentang disusun dari rilis peringkat Fudan 2021-2025, hanya sebagai referensi.
Dokter representatif
- Prof. Ji Jiafu · GI oncology surgery
- Ji Jiafu · GI oncology surgery, gastric cancer
- Shen Lin · GI medical oncology
- GI surgery team · Laparoscopic gastrectomy
- Thoracic oncology team · Targeted and immune therapy
- Breast centre team · Breast-conserving surgery and endocrine therapy
- Radiation oncology team · SBRT and IMRT
Daftar ahli dari sumber publik dan situs resmi rumah sakit; ketersediaan dan jabatan dapat berubah — verifikasi ke rumah sakit sebelum memesan.
Berita & tonggak sejarah
Multicentre study on standardised gastric cancer surgery
Randomised trials examine lymph-node dissection extent and perioperative therapy.
Molecular subtyping guides precision therapy
Genomic testing matches colorectal and gastric cancer patients to targeted and immune regimens.
Hereditary cancer counselling clinic opens
Genetic testing and risk management for familial breast and colorectal cancer.
Medical team dispatched to Wuhan
Oncology and critical-care staff served in designated hospitals.
SBRT programme expands
SBRT is applied to early lung cancer, liver cancer and oligometastases.
Tonggak dirangkum dari laporan publik tepercaya dan rilis resmi; judul adalah ringkasan.
Kerja sama internasional
- It joins IGCA multicentre studies and exchanges case discussions with Japanese and Korean gastric cancer centres.
- Trial collaboration with European and US centres includes eligibility assessment for international patients.
- The international office offers English oncology consultation, pathology review and MDT opinions.
Informasi kerja sama dirangkum dari sumber publik; merujuk rilis resmi rumah sakit.
Kolaborasi universitas
Peking University Health Science Center
Riset & publikasi
Leading national work on gastric and colorectal cancer trials, molecular subtyping and targeted therapy.
Dirangkum dari sumber publik (Oktober 2026). Cek situs resmi rumah sakit sebelum berangkat.